Skip to main content

Company

CareFirst

32 published works

  1. Big Molecule Watch

    Parties Dispute Intent Standard in STELARA® Antitrust Appeal

    By Harrison Gunn

    As we previously reported, portions of CareFirst’s antitrust claims concerning STELARA® (ustekinumab) survived summary judgment in December 2025. On January 14, 2026, the U.S. District Court for the Eastern District…

  2. Truth on the Market

    Four Patents and a Time Machine: CareFirst and the Perils of Backdated Antitrust

    By Alden Abbott

    Four patents can carry a lot of antitrust baggage—especially when they come tucked inside a portfolio of more than 500. In CareFirst of Maryland v. Johnson & Johnson, health insurer…

  3. eDiscovery Today Blog

    Privilege Log May Be Admissible, Court Rules: eDiscovery Case Law

    By Doug Austin

    In CareFirst of Md., Inc. v. Johnson & Johnson, Virginia District Judge Jamar K. Walker ruled that certain “uses of J&J's privilege log may be admissible subject to CareFirst laying…

  4. Big Molecule Watch

    CareFirst’s Class Action STELARA® Antitrust Case Against J&J Will Proceed: Court Grants-in-Part and Denies-in-Part Class Certification and Denies the Parties’ Motions for Summary Judgment

    By Allegra Padula|Kevin DeJong

    As we have previously reported, a group of health insurers and health insurance administrators (collectively, “CareFirst”) filed a class action complaint in 2023 against Johnson & Johnson and Janssen Biotech,…

  5. Inside Class Actions

    D.D.C.’s Application of <em>TransUnion </em>Echoes the Importance of Actual Injury to Class Certification

    By Kathryn Cahoy

                In Attias v. CareFirst, Inc., 15-cv-00882-CRC (D.D.C. Mar. 28, 2023), the court’s application of TransUnion v. Ramirez, 141 S. Ct. 2190 (2021), reinforced that inclusion of uninjured class members…

  6. Big Molecule Watch

    American Academy of Ophthalmology Pushes Back Against Bevacizumab Biosimilar Use in Treating Ophthalmic Conditions

    By Harrison Gunn

    On July 29, 2021, the American Academy of Ophthalmology (AAO) released a statement urging the Centers for Medicare & Medicaid Services (CMS) to prohibit Insurance companies from requiring ophthalmologists to…

  7. Paul W. Mollica Federal Courts Blog

    Perfunctory Fed. R. Civ. P 54(b) Certification Fails to Confer Appellate Jurisdiction, Holds D.C. Circuit

    By Paul W. Mollica

    In a breach-of-privacy action, Attias v. CareFirst, Inc., No. 19-7020 (D.C. Cir. Aug. 11, 2020), the D.C. Circuit holds that the district court’s failure to explain his Rule 54(b) dismissal…

  8. Declassified

    Yes, But Were You Hurt? Another Data Breach Case Dismissed for Lack of Damages

    By J. Thomas Richie, John E. Goodman

    While a war rages on the issue of standing in data breach cases, the need to prove damages is presenting an even greater hurdle for plaintiffs, as we have noted…

  9. Cleary Cybersecurity and Privacy Watch

    Supreme Court Declines to Review Standing in the Data Breach Context Despite Ongoing Circuit Split

    By Rahul Mukhi, Tanner Mathison

    Late last month, the Supreme Court declined to review the D.C. Circuit’s decision in CareFirst v Attias.  In CareFirst, the D.C. Circuit ruled that the mere theft of personal information…

  10. Privacy and Cybersecurity Perspectives

    SCOTUS Denies Cert on CareFirst: No Clarity on Harm in Data Breach Cases This Session

    By Daniel J. Kagan

    On February 16, 2018, the U.S. Supreme Court denied certiorari to review CareFirst’s appeal of the U.S. Court of Appeals, D.C. Circuit’s decision in Attias v. Carefirst, Inc., 865 F.3d 620…